Three Years Follow Up Of The ARIS™ Trans-Obturator Tape
Main Category: Urology / NephrologyArticle Date: 11 Nov 2008 - 1:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
MONTEREY, CA, USA (UroToday.com) - Dr. Saad Juma presented his experience in 234 patients who had completed a 12 to 26 month (mean 23.3) questionnaire follow up after placement of an Aris™ transobuturator sling. The group reported resolution of SUI in 90.61% of the patients, of urge incontinence in 61.81%, and only 2.51% (n=2) with de novo urgency symptoms.
Each of the questionnaires used in the study, the Urogenital Distress Inventory (UDI-6), the Incontinence Impact Questionnaire (IIQ-7), and the Global Symptom Index, showed statistically significant improvements from pre- to post-operative assessment.
Complications were minimal and included vaginal tape extrusion in 1.3% (n=3), urinary tract infection in 0.9% (n=2), and necessity for tape release for treatment of BOO in 0.9% (n=2).
Presented by Saad Juma, MD, at the 84th Annual Meeting of the AUA - Western Section - October 26 - 30, 2008 - Monterey, California
Reported by Alvaro Lucioni, MD, Virginia Mason Medical Center, Seattle, WA.
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2008 - UroToday
Visit our urology / nephrology section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/128736.php>
APA
http://www.medicalnewstoday.com/releases/128736.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



